X-Zell

Early, pain-free cancer detection.

Y CombinatorWinter 2015ActiveHealthcareDiagnosticsMedical Devices

What they do

Problem

Cancer and other diseases are hard to detect early and pain-free because rare abnormal cells in blood are difficult to isolate and analyze reliably.

Solution

A patented in-house platform that processes blood to isolate, visualize, and analyze rare cells such as circulating endothelial cells and generate clinical reports.

Who it's for

Clinical labs and healthcare providers seeking blood-based early cancer detection and rare-cell analysis.

Founders

Sebastian Punyaratabandhu Bhakdi

Founder

Sebastian started out as a physician at the University Hospital of Freiburg, Germany and earned a Degree in International Health at the Autonomous University of Barcelona, Spain, which made him realize that health services have to be accessible for all. A Research Fellowship from the German Research Foundation helped him to create his first patent which he used to found X-ZELL. He remains its CEO and Principal Investigator, growing the company to solve the world's cancer screening challenge.